The Complete Guide to Chemical Exfoliation: AHA/BHA Synergy

Chemical exfoliation has displaced physical scrubbing as the preferred exfoliation modality in evidence-based skincare—not because acids are trendy but because the mechanism is demonstrably superior for most skin concerns. Physical scrubbing produces irregular surface abrasion; chemical exfoliation targets specific biological structures (corneocyte adhesions, follicular keratinization) with predictable depth and extent of effect. The ingredient class—AHA or BHA—determines which structures are targeted, which skin conditions benefit, and which concentration and pH are required for efficacy.

Yet confusion about AHA and BHA selection is endemic in consumer skincare. The dominant misconception is that AHAs are "for dry skin" and BHAs are "for oily skin"—a useful simplification that obscures the actual chemical and biological distinctions that make each acid appropriate for specific conditions. This guide establishes the chemistry, mechanism, and evidence-based application of both acid classes, and maps the specific synergies that emerge from combined use.

Alpha-Hydroxy Acids: Chemistry and Mechanism

Alpha-hydroxy acids are organic acids with a hydroxyl group (-OH) on the carbon adjacent to the carboxylic acid group (the alpha carbon). The class includes glycolic acid (derived from sugarcane), lactic acid (derived from milk), malic acid (from apples), tartaric acid (from grapes), mandelic acid (from bitter almonds), and citric acid. Glycolic and lactic acid are by far the most used in skincare formulations.

AHAs exfoliate through a mechanism that is both chemical and biological: at acidic pH (below approximately 3.5–4.0 for glycolic acid), they weaken the calcium ion-dependent cohesion between corneocytes in the lower stratum corneum layers. The desmosomes that hold corneocytes together require calcium ion bridging; AHAs chelate calcium ions, disrupting the bridges and allowing the most superficial corneocyte layers to shed. This produces "controlled desquamation"—accelerated shedding of the topmost dead cell layers without disrupting the viable epidermis.

The depth of effect is primarily a function of concentration and pH, with contact time as a secondary variable. At concentrations below 8% at consumer-appropriate pH (3.5–4.5), AHA effect is confined to the superficial stratum corneum. At 10–30% and pH 2.5–3.5 (professional peel territory), the desquamation effect extends into the deeper stratum corneum and can reach the stratum granulosum. At concentrations above 30% (medical-grade), the effect can penetrate to the epidermis proper, the territory of genuine chemical peels.

The Molecular Size Factor: Glycolic vs. Lactic vs. Mandelic

Within the AHA class, molecular size determines penetration depth and speed of effect. Glycolic acid has the smallest molecular size (76 g/mol) of any AHA and penetrates the stratum corneum most rapidly and deeply. This translates to faster efficacy and higher irritation potential at equivalent concentrations. Lactic acid (90 g/mol) has slightly reduced penetration and a marginally gentler profile. Mandelic acid (152 g/mol) is the largest commonly used AHA and has the most restricted penetration—the gentlest AHA with the slowest onset of effect, often well-tolerated by sensitive and rosacea-prone skin.

The practical implication: glycolic acid at 8% pH 3.5 produces more rapid and pronounced desquamation than mandelic acid at 8% pH 3.5. For those with normal-to-resilient skin seeking faster results, glycolic is the appropriate choice. For sensitive skin or the first introduction to chemical exfoliation, mandelic or lactic acid at lower concentrations (5–8%) is the correct starting point.

Lactic Acid: Beyond Exfoliation

Lactic acid has an advantage over glycolic acid that is mechanistically independent of its exfoliating action: it is a natural moisturizing factor (NMF) component. At lower concentrations (5–12%), lactic acid stimulates ceramide synthesis in keratinocytes, increases filaggrin expression (a key protein in barrier assembly), and functions as a humectant in the intercellular matrix. A formulation containing 10% lactic acid is simultaneously exfoliating the stratum corneum and augmenting the NMF components of the same tissue—a dual action that makes lactic acid the preferred AHA for dry, dehydrated, or barrier-compromised skin.

This barrier-supporting duality also explains why lactic acid has demonstrated efficacy for skin conditions associated with abnormal desquamation and barrier dysfunction—ichthyosis vulgaris, xerosis, and lamellar ichthyosis—at concentrations of 12–24%, where the barrier-building effects are the primary therapeutic goal.

Salicylic Acid: The BHA Class

Beta-hydroxy acid in skincare is, in practice, a single compound: salicylic acid (2-hydroxybenzoic acid, molecular weight 138 g/mol). The "beta" nomenclature refers to the hydroxyl group being on the beta carbon relative to the carboxyl group in the classic BHA naming convention (though salicylic acid's aromatic structure makes this technically a simplified classification). The BHA class's defining clinical distinction is lipid solubility.

Salicylic acid is lipophilic—it dissolves in oils and lipid-containing environments. AHAs are hydrophilic—they dissolve in water. The stratum corneum intercellular matrix and the sebaceous follicle lumen are lipid-rich environments. Salicylic acid can penetrate these lipid-rich structures where AHAs cannot. This penetration into the follicle lumen is the mechanism behind salicylic acid's comedolytic (comedo-dissolving) action: it exfoliates the keratinized cells lining the follicle and breaks down the desmosome adhesions that cause follicular keratinocytes to accumulate and obstruct the pore.

The consequence is that salicylic acid reaches the primary site of comedone formation (the follicular infundibulum) while glycolic acid—being water-soluble—cannot access this lipid environment regardless of concentration. This is the actual mechanistic basis for the "BHA is for oily/acne-prone skin" generalization, which is accurate but insufficiently specific: BHA is for conditions where follicular keratinization and comedone formation are the primary pathology, because BHA is the only exfoliant that can reach the follicle.

The Synergy: Why Combined AHA/BHA Outperforms Either Alone

The synergy between AHAs and BHAs emerges from their complementary mechanisms and tissue targets. AHAs (particularly glycolic and lactic) address the surface stratum corneum—accelerating desquamation of the topmost layers, stimulating epidermal renewal, and (in the case of lactic acid) supporting the NMF. BHAs address the follicular environment—dissolving intrafollicular keratin plugs, reducing comedone formation, and delivering mild anti-inflammatory effects (salicylic acid is a derivative of aspirin and retains some prostaglandin-synthesis-inhibiting activity at the concentrations used topically).

Combined use targets both pathologies simultaneously. For acne-prone skin, the AHA component addresses the hyperpigmentation and texture irregularities of post-acne skin while the BHA component prevents new comedone formation. For photoaged skin with enlarged pores, the AHA component drives the surface renewal and collagen stimulation pathways while the BHA component clears follicular debris that makes pores appear larger. No single acid class accomplishes both.

The combination also allows lower concentrations of each acid to achieve effects equivalent to higher concentrations of either acid alone—the complementary mechanisms reduce the requirement for high individual acid concentrations, which reduces irritation. A formulation containing 5% glycolic acid + 2% salicylic acid at appropriate pH has demonstrated outcomes in controlled trials comparable to 10% glycolic acid alone for texture improvement, with significantly lower rates of irritation.

Concentration and pH: The Efficacy Parameters

Both concentration and pH must be within effective ranges for AHA/BHA activity to occur. This is the single most important—and most frequently overlooked—specification parameter for evaluating exfoliating products.

For glycolic acid: effective concentration range 5–30%; effective pH range 2.5–4.5. Below pH 4.5, the acid exists predominantly in its undissociated (protonated) form, which is the penetrating form. Above pH 4.5, the acid is predominantly dissociated (deprotonated, existing as glycolate anion) and has significantly reduced penetration—it is essentially inert as an exfoliant regardless of concentration. Many "AHA" products on the market have pH above 4.5 and are therefore clinically ineffective, regardless of the AHA concentration listed on the label.

For salicylic acid: effective concentration range 0.5–2% (concentrations above 2% provide little additional comedolytic effect); effective pH range 3.0–4.0. Salicylic acid at pH above 4.0 is substantially less effective.

Consumer-available pH test strips (or a digital pH meter) are sufficient to assess whether a product is within the effective pH range. Many skincare brands publish product pH on their websites or upon direct inquiry; others do not. This information asymmetry disadvantages the consumer and benefits low-quality product formulations.

Building an Exfoliation Protocol: Frequency and Sequencing

Exfoliation frequency is primarily a function of skin barrier resilience. Over-exfoliation is the most common misuse pattern—daily use of high-concentration AHA at optimal pH by a new user will reliably produce barrier disruption, redness, and paradoxical texture worsening, leading the user to conclude the product "doesn't work" or "broke them out."

Beginners: 1–2× per week with an AHA/BHA combination toner or pad at moderate concentration (7–8% AHA, 1–2% BHA, pH 3.5–4.0). Intermediate: 3–4× per week as tolerance develops over 4–8 weeks. Advanced/experienced users: up to nightly use for toners at moderate concentration; 2–3× weekly for higher-concentration treatments.

Sequencing in a routine: apply acid toners or treatments to clean, dry skin before serums and moisturizers. Wait 15–20 minutes before applying retinoids (do not combine acids and retinoids in the same step—the combined acidity disrupts retinoid stability and significantly increases irritation). Apply SPF every morning after any exfoliant use—AHAs and BHAs increase UV sensitivity by removing the protective dead cell layer and should always be paired with photoprotection.

The Limits: When Chemical Exfoliation Is Inappropriate

Active barrier disruption (eczema flare, rosacea flare, sunburn, post-procedure skin) contraindicates chemical exfoliation—acid application to disrupted barrier bypasses the dose-control mechanism and produces unpredictable, potentially severe irritation. Concurrent use with prescription retinoids requires careful management—the combination is powerful and effective but must be staggered (retinoid on alternating nights from exfoliant) to prevent barrier damage.

Fitzpatrick types V and VI require particular attention with glycolic acid—the melanin-stimulating effect of glycolic acid inflammation can produce PIH in darker skin types at concentrations that are well-tolerated in lighter skin. Lower concentrations, lactic or mandelic acid, and strict anti-inflammatory protocol reduce this risk.